TYRX™ Envelope for Prevention of Infection Following Replacement With a CRT or ICD

Completed

Conditions studied: Cardiac Implantable Electronic Device Infection

In brief

The purpose of this study is to compare the incidence of cardiac implantable electronic device (CIED) infection and CIED mechanical complication after CIED replacement with a high-power cardiac implantable electronic device; either a cardiac resynchronization therapy device (CRT), or an implantable cardioverter defibrilator (ICD) and TYRX Anti-Bacterial Envelope (formerly known as "AIGISRx"), to the incidence, after replacement with an ICD or CRT and no TYRX.

Key facts

Study ID
NCT01043705
Run by
TYRX, Inc.
People needed
1262
Starts
2010-01-01
Expected to finish
2015-05-01
Last updated by the study team
2015-12-24

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.